Dostarlimab+chemotherapy for the treatment of primary advanced or recurrent endometrial cancer: The placebo-controlled randomised phase III RUBY trial
Presenter: Mansoor Mirza, Denmark; Discussant: Ilaria Colombo, Switzerland; AACR expert commentary: Elise C. Kohn, USA